This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Vornado (VNO) Q1 FFO & Revenues Miss Estimates, NOI Down
by Zacks Equity Research
Vornado Realty's (VNO) first-quarter 2019 performance impacted by lower occupancy and net operating income from the company's New York and theMART portfolios.
Welltower (WELL) Q1 FFO Meets Estimates, Revenues Up Y/Y
by Zacks Equity Research
Welltower's (WELL) Q1 results reflect growth in same-store net operating income, buoyed by decent performance across all of its operating segments.
Ventas' (VTR) Q1 FFO & Revenues Beat Estimates on NOI Growth
by Zacks Equity Research
While Ventas' (VTR) Q1 results display strength in office and triple net leased portfolio, lower revenues hurt results to some extent.
Why Earnings Season Could Be Great for Ventas (VTR)
by Zacks Equity Research
Ventas (VTR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Can Favorable Demographics Drive Ventas' (VTR) Q1 Earnings?
by Zacks Equity Research
Ageing demography will likely help Ventas (VTR) witness higher absorption of its seniors housing assets. Also, investment in university-based Research & Innovation (R&I) is a strategic fit.
Why SL Green Realty (SLG) Might Surprise in Q1 Earnings
by Zacks Equity Research
Leveraging on favorable office real estate trends, SL Green Realty (SLG) enters into lease agreements, as well as announces redevelopment projects in Q1.
What's in the Cards for Crown Castle (CCI) in Q1 Earnings?
by Zacks Equity Research
Though Crown Castle International's (CCI) site-rental revenues are expected to witness continued growth amid robust tailwinds, consolidation in the wireless industry remains a concern.
Should You Hold Ventas (VTR) Stock in Your Portfolio Now?
by Zacks Equity Research
While Ventas' (VTR) investments in medical office and life-science real estate portfolio seem apt given the rise in ageing demography, escalating supply of senior housing assets is a concern.
Healthcare Realty Completes MOB Buyouts in Potential Markets
by Zacks Equity Research
Healthcare Realty (HR) completes purchase of four properties, amid soaring popularity for medical-office buildings.
Healthcare Realty (HR) Prices Offering of 3.25M Common Stock
by Zacks Equity Research
Healthcare Realty's (HR) latest public offering of common stock will improve its financial flexibility and provide ample scope for deploying capital in accretive acquisitions.
Ventas (VTR) Down 3.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ventas (VTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HT or VTR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HT vs. VTR: Which Stock Is the Better Value Option?
Mack-Cali's (CLI) Q4 FFO Meets, Revenues Miss Estimates
by Zacks Equity Research
Mack-Cali Realty's (CLI) fourth-quarter 2018 results indicate softness in its office portfolio. In fact, subdued leasing activity and decline in same-store cash net operating income disappoint.
SITE Centers (SITC) Q4 FFO Beats, Revenues Miss Estimates
by Zacks Equity Research
While SITE Centers (SITC) posts better-than-expected results, backed by healthy leasing activity, rent and same-store net operating income (NOI) growth, declining revenues remains a concern.
Lamar Advertising (LAMR) Q4 AFFO Tops Estimates, Revenues Up
by Zacks Equity Research
Lamar Advertising (LAMR) witnesses bottom-line growth on higher revenues and solid operating income in the fourth quarter.
Host Hotels' (HST) Q4 FFO Beats Estimates, Revenues Up Y/Y
by Zacks Equity Research
Host Hotels & Resorts' (HST) Q4 results reflect improvements in food and beverage revenues and productivity gains. Further, year-over-year growth in comparable hotel RevPAR is encouraging.
HCP Meets Q4 FFO Estimates, Misses on Revenues, Issues View
by Zacks Equity Research
HCP's fourth-quarter 2018 results marred by continued decline in senior-housing operating portfolio cash net operating income.
Iron Mountain (IRM) Tops Q4 FFO Estimate, Misses on Revenues
by Zacks Equity Research
Iron Mountain Incorporated's (IRM) performance in fourth-quarter 2018 reflects decent organic growth in storage and services revenues. The company issues outlook for 2019 as well.
Equinix (EQIX) Q4 FFO Surpasses Estimates, Revenues Up Y/Y
by Zacks Equity Research
Equinix (EQIX) records year-over-year growth in revenues backed by strong performance of the company's Americas, EMEA and Asia-Pacific portfolios.
Welltower (WELL) Misses Q4 FFO Estimates, Reaffirms '19 View
by Zacks Equity Research
Welltower's (WELL) Q4 results reflect healthy same-store net operating income (SSNOI) performance across all of its operating segments.
Vornado Realty (VNO) Misses Q4 FFO Estimates on Lower NOI
by Zacks Equity Research
Vornado Realty's (VNO) fourth-quarter results reflect dismal performance of its New York and theMART portfolios. Further, the company exited the quarter with lower liquidity.
Ventas' (VTR) Q4 FFO & Revenues Top Estimates, NOI Up Y/Y
by Zacks Equity Research
Ventas' (VTR) fourth-quarter results display revenue growth, supported by higher rental income from its office segment.
HT vs. VTR: Which Stock Is the Better Value Option?
by Zacks Equity Research
HT vs. VTR: Which Stock Is the Better Value Option?
Ventas (VTR) Q4 FFO and Revenues Beat Estimates
by Zacks Equity Research
Ventas (VTR) delivered FFO and revenue surprises of 1.05% and 0.86%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Liberty Property (LPT) Q4 FFO Tops, Gives Sears Impact Update
by Zacks Equity Research
Liberty Property's (LPT) Q4 results highlight rent escalation in industrial portfolio. It plans an aggressive push toward concluding its repositioning efforts and issued the Sears bankruptcy impact.